Congenital varicella syndrome is a rare condition that affects a baby when chickenpox infection occurs early in pregnancy. It can cause birth features such as skin scarring, limb underdevelopment, eye problems, and low birth weight. Babies with congenital varicella syndrome may also have feeding difficulties, seizures, or developmental delays, and the pattern can vary. Care focuses on supportive therapies, eye and limb care, seizure control, and early developmental services. Prevention through maternal varicella vaccination before pregnancy reduces risk, and outcomes depend on which organs are affected.
Overview
Congenital varicella syndromeSymptoms
Congenital varicella syndrome features are usually noticed before birth or at delivery. Babies may have skin scarring, underdeveloped or missing fingers or toes, eye problems that affect vision, small head and body size, weak muscle tone, seizures, or developmental delays.
Outlook and prognosis
Most babies with congenital varicella syndrome face lifelong challenges, which can include vision or hearing loss, limb differences, growth delays, or learning difficulties. Outcomes vary widely, depending on which organs were affected and how early injury occurred. With coordinated pediatric, eye, hearing, and developmental care, many children gain skills and quality of life.
Causes and risk factors
Caused by a mother’s primary varicella-zoster (chickenpox) infection in early pregnancy, when the virus crosses the placenta. Highest risk between weeks 8–20, especially if not immune or unvaccinated. Exposure to chickenpox, outbreaks, or immunosuppression increases risk; it isn’t inherited.
Genetic influences
Genetics plays little to no role in congenital varicella syndrome; it results from varicella-zoster virus exposure during early pregnancy. Inherited variants don’t drive risk. Rare immune-related differences may influence severity, but maternal infection timing is the key factor.
Diagnosis
Diagnosis of congenital varicella syndrome uses maternal chickenpox history and characteristic clinical features. Prenatal ultrasound or fetal MRI may show limb, brain, or eye abnormalities. Confirmation can include chickenpox virus PCR from amniotic fluid or newborn lesions.
Treatment and drugs
Treatment for congenital varicella syndrome focuses on each child’s needs, such as managing eye, skin, or limb differences, supporting development, and monitoring growth. Care may include eye care, physical and occupational therapy, and hearing support. Pediatric specialists coordinate long‑term follow‑up.
Symptoms
Early features of congenital varicella syndrome often show up at birth or in the first months, and they can affect how a baby sees, moves, feeds, and grows. Some changes are visible, like band-like skin scarring or a shorter arm or leg; others are quieter, such as vision or brain differences that become clearer as a child develops. Features vary from person to person and can change over time.
Patchy, band-like scars may appear on the skin, often along part of an arm, leg, or trunk. In congenital varicella syndrome, these lines reflect changes that happened before birth. They do not spread or itch but can be sensitive.
An arm or leg may be smaller, shorter, or have fewer fully formed fingers or toes. With congenital varicella syndrome, this often affects one side and can make reaching, walking, or shoe fit trickier. Physical therapy and adaptive gear can help daily tasks.
Weakness or limited movement can affect the same limb, sometimes from nerve or spinal cord involvement. This can change how a child grasps toys or bears weight. Braces or targeted exercises may improve function.
Cataracts, a small eye, or scarring in the back of the eye can reduce vision. In congenital varicella syndrome, vision may be normal in one eye and limited in the other. Early eye care guides options like glasses, patches, or surgery.
How people usually first notice Congenital varicella syndrome?
Parents and clinicians often first notice signs during pregnancy, when an ultrasound shows findings like underdeveloped limbs, small head size, or growth restriction after the mother had chickenpox (varicella) in the first 20 weeks. At birth, the first signs of congenital varicella syndrome may include a low birth weight, limb abnormalities, eye problems such as cataracts or scarring, and distinctive skin scarring in streaks or patches. As infants grow, some families first recognize concerns through feeding difficulties, seizures, or developmental delays that prompt evaluation of how congenital varicella syndrome is first noticed.
Types of Congenital varicella syndrome
Congenital varicella syndrome can look different from one pregnancy to the next because timing of the mother’s chickenpox infection and the baby’s stage of development both matter. When infection happens very early, patterns tend to be more severe and widespread; later in pregnancy, effects are usually more limited. Symptoms don’t always look the same for everyone. Below are the main types of features doctors commonly group together when they describe the types of congenital varicella syndrome by timing and impact.
First-trimester exposure
Infection in the first 13 weeks is linked to the highest risk of classic features like limb underdevelopment, eye problems, and skin scarring. Growth can be restricted and the nervous system may be affected. These early symptoms of congenital varicella syndrome often come as a cluster.
Early second-trimester exposure
Infection around 14–20 weeks can produce similar findings but often fewer areas are involved. Limb differences and eye findings may still appear, and growth can lag. Neurologic effects can range from mild to more noticeable delays.
Late second/third trimester exposure
Infection after about 20 weeks rarely causes the classic pattern but can still lead to shingles (zoster) in infancy and subtle neurologic or eye issues. Many babies have normal structure at birth but may develop zoster months later. Overall risk of severe anomalies is lower than with earlier exposure.
Zoster in infancy
Some infants exposed late in pregnancy develop shingles without the full congenital pattern. This can show up as a painful stripe-like rash and nerve irritation. Long-term outcomes are usually good once the episode resolves.
Asymptomatic exposure
Many pregnancies with maternal chickenpox—especially later in gestation—result in healthy infants with no signs at birth. Care teams may still arrange eye and hearing checks to be safe. Follow-up helps catch any delayed issues early.
What genetics can tell you about symptoms
Some babies with congenital varicella syndrome develop limb underdevelopment, skin scarring, cataracts, or small head size because early pregnancy infection lets varicella-zoster virus damage tissues while genes guiding growth are still active and vulnerable. Specific viral genes disrupt nerve and eye development, leading to seizures or vision loss.
Causes and risk factors
Congenital varicella syndrome occurs when a pregnant person gets chickenpox for the first time early in pregnancy. The risk of congenital varicella syndrome in early pregnancy is highest before 20 weeks and becomes very low in late pregnancy. Biological and environmental risks include no prior immunity, close contact with someone who has chickenpox, and jobs or home settings with frequent exposure to children. Doctors distinguish between risk factors you can change and those you can’t. There is no genetic cause, and shingles in the parent is unlikely to cause congenital varicella syndrome.
Environmental and biological risk factors
Risk of congenital varicella syndrome depends on whether, and when, varicella (chickenpox) infection happens during pregnancy. Doctors often group risks into internal (biological) and external (environmental). The factors below describe what can increase the chance that the virus reaches the placenta and fetus.
Getting chickenpox for the first time during pregnancy lets the virus enter the blood, which can cross the placenta. Fetal infection is the necessary first step for congenital varicella syndrome.
Infection in the first or early second trimester, especially around weeks 8 to 20, carries the highest fetal risk. Infection later in pregnancy rarely leads to congenital varicella syndrome.
Without existing varicella antibodies, someone who is pregnant is more likely to become infected after exposure. Without maternal antibodies to pass across the placenta, the fetus has less protection.
Living with, caring for, or close contact with someone who has chickenpox or shingles increases exposure. Higher exposure raises the chance of virus in the blood and spread to the fetus.
Genetic risk factors
For congenital varicella syndrome (CVS), there is no direct inherited, gene‑based cause. Most genetic influences relate to how the mother’s immune system controls the varicella virus during pregnancy. Some risk factors are inherited through our genes, such as rare immune system disorders that weaken T‑cell responses. When people ask about genetic risk factors for congenital varicella syndrome, the key point is that family history usually does not raise risk unless there is a known inherited immunodeficiency.
Not inherited: There is no known gene or mutation that makes congenital varicella syndrome pass from one generation to the next. A previous family history of CVS does not raise the chance in a later pregnancy.
Maternal immunodeficiency: Rare inherited conditions that weaken T‑cell–based immunity can make varicella in the mother more severe or longer-lasting. When these primary immunodeficiencies are present, the fetus may face higher risk if maternal varicella occurs.
Fetal genetics: No consistent fetal genetic variants have been proven to increase or decrease the chance of congenital varicella syndrome. Differences in outcome between pregnancies are not explained by the baby’s inherited traits based on current evidence.
Family history: Having relatives with severe chickenpox or shingles does not, by itself, create a genetic risk for congenital varicella syndrome. Unless a known inherited immunodeficiency runs in the family, relatives’ experiences do not change your baseline genetic risk.
Genetic testing: Routine genetic testing is not used to predict congenital varicella syndrome risk. Testing may be considered only when there are clear signs of an inherited immune disorder in the mother, such as recurrent severe infections.
Lifestyle risk factors
Lifestyle habits do not cause congenital varicella syndrome, but they can meaningfully influence symptoms, function, and complications over time. This section focuses on how lifestyle affects congenital varicella syndrome in practical ways. Put another way, these are the lifestyle risk factors for congenital varicella syndrome that can either ease day-to-day challenges or make them worse.
Regular, therapist-guided activity can improve muscle strength, balance, and joint range in people with CVS-related limb hypoplasia. It can limit contractures and support motor development.
Consistent use of splints, braces, and proper seating helps align joints affected by hypoplasia. This can reduce pain, prevent contractures, and improve mobility.
A diet that meets higher protein and calorie needs supports catch-up growth and wound healing in children with CVS who have failure to thrive. Micronutrient sufficiency (vitamin D, calcium, iron) supports bone health and development.
For infants with oral-motor or swallowing difficulties from neurologic involvement, paced feeds, thickened liquids, or specialized nipples can reduce aspiration risk. Working with feeding therapy can improve intake and growth.
Risk prevention
Congenital varicella syndrome is best prevented by stopping chickenpox infection during early pregnancy. True prevention means being immune before conception, and quick action if exposure happens while pregnant. If infection does occur, treatments may reduce illness severity and may lower the chance of fetal harm, especially early symptoms of congenital varicella syndrome. Different people need different prevention strategies—there’s no single formula.
Getting the varicella vaccine before pregnancy offers strong protection against chickenpox. Two doses, given at least 4 weeks apart and finished at least 1 month before trying to conceive, are recommended. This “varicella vaccine before pregnancy” step is the most effective way to prevent congenital varicella syndrome.
Ask your clinician to confirm immunity with past vaccine records or a simple blood test. If you’re not immune, plan vaccination before pregnancy or right after delivery so you’re protected for a future pregnancy.
Stay away from anyone with chickenpox or shingles, especially during the first 20 weeks of pregnancy. The virus spreads easily from coughing and from skin blisters, starting 1–2 days before the rash.
If you’re pregnant, not immune, and exposed, varicella‑zoster immune globulin (VZIG) within 10 days—ideally within 4 days—may reduce illness and lower fetal risk. Ask urgently about post-exposure prophylaxis for varicella in pregnancy.
Transmission
Congenital varicella syndrome occurs when the chickenpox virus (varicella-zoster virus) passes through the placenta during pregnancy, usually when a pregnant person gets chickenpox for the first time, most often in the first 20 weeks. This is mother-to-baby transmission through the placenta; it is not inherited, and you cannot catch congenital varicella syndrome from someone else. The transmission of congenital varicella syndrome depends on timing: the risk is greatest with infection around weeks 13 to 20 of pregnancy and is very rare later on. While chickenpox itself is highly contagious to people who haven’t had it or been vaccinated, congenital varicella syndrome is not contagious. Shingles (reactivated varicella) during pregnancy rarely leads to this syndrome.
When to test your genes
Consider genetic testing if you had varicella (chickenpox) during early pregnancy and your clinician is evaluating fetal effects, or if ultrasound shows features suggestive of congenital varicella syndrome. Testing typically targets the virus (maternal, amniotic fluid, or fetal samples), not your genes. Preconception counseling can also guide immune testing and vaccination planning.
Diagnosis
When chickenpox (varicella) occurs early in pregnancy, teams look for certain signs in the fetus or newborn that suggest congenital effects. Early and accurate diagnosis can help you plan ahead with confidence. The diagnosis of congenital varicella syndrome combines the timing of infection with characteristic features and focused tests. Care often involves obstetrics, pediatrics, and infectious disease working together.
Providers note if chickenpox happened in the first half of pregnancy and the exact week it started. This timing helps estimate the baby’s risk for congenital varicella syndrome.
Blood tests in the pregnant person can confirm a recent varicella infection. This context supports the diagnosis of congenital varicella syndrome when fetal or newborn findings are present.
Ultrasound may show limb underdevelopment, growth restriction, or brain changes such as enlarged fluid spaces. Doctors also look for signs like abnormal amniotic fluid levels or hydrops.
MRI can take a closer look at the baby’s brain and spine if ultrasound finds possible concerns. It helps clarify the extent of neurologic involvement before birth.
Stages of Congenital varicella syndrome
Congenital varicella syndrome does not have defined progression stages. It stems from chickenpox during early pregnancy, and its effects are usually present at birth rather than unfolding gradually over time. Diagnosis is based on your pregnancy history and the baby’s exam, sometimes supported by ultrasound before birth and eye, skin, limb, and nerve checks after birth; different tests may be suggested to help confirm the cause and understand which body systems are affected. Doctors then monitor growth and development, and may look for early symptoms of congenital varicella syndrome—such as feeding problems, vision concerns, or limb weakness—to guide care and therapies.
Outlook and prognosis
Many people ask, “What does this mean for my future?”, and the answer varies depending on which organs were affected before birth and how early care begins. The outlook for congenital varicella syndrome ranges from mild, manageable challenges to significant lifelong disabilities. Some babies have low birth weight, limb differences, skin scarring, or eye and brain involvement; over time, these can influence movement, vision, learning, and growth. In severe cases—especially with extensive brain or multiple‑organ involvement—there is a higher risk of infant death, most often in the first year. Early care can make a real difference, particularly when hearing, feeding, seizures, or vision issues are addressed promptly.
As children with congenital varicella syndrome grow, the long-term picture depends on the mix of needs: orthopedic care for limb issues, ophthalmology for cataracts or scarring, neurology for seizures or developmental delays, and supportive therapies to build skills. Prognosis refers to how a condition tends to change or stabilize over time. Some children achieve good function with therapies and assistive devices, attend school with supports, and develop increasing independence; others require ongoing, high‑level care. When early symptoms of congenital varicella syndrome are identified and treated, hospitalizations and complications can often be reduced.
Looking at the long-term picture can be helpful. With coordinated care, many people maintain stable health and avoid severe complications, but the outlook for congenital varicella syndrome is not the same for everyone. For families thinking about future pregnancies, the condition itself is not inherited; risk relates to chickenpox infection during pregnancy, which can be prevented with vaccination before conception. Talk with your doctor about what your personal outlook might look like.
Long-term effects
For many living with congenital varicella syndrome, the long-term picture focuses on how early injuries affect growth, movement, vision, and learning over time. While early signs of congenital varicella syndrome are often noticed at birth, the lasting effects tend to unfold across childhood and adolescence. Long-term effects vary widely, and the mix of challenges can differ even among people with similar findings. Some features remain stable, while others become more noticeable as children grow and daily demands increase.
Underdeveloped or missing parts of an arm or leg can affect balance, walking, and hand use. Joint stiffness or contractures may limit range of motion over time. These differences in congenital varicella syndrome often remain lifelong.
Eye changes like cataracts or scarring at the back of the eye can reduce clarity or field of vision. For some, this leads to low vision or, less often, blindness. Vision needs may shift as children with congenital varicella syndrome grow.
Brain development differences can lead to intellectual disability, muscle stiffness or low tone, and seizures. Coordination and fine motor skills may be affected. These neurologic effects in congenital varicella syndrome are typically long-lasting.
Many children show delays in speech, motor milestones, or school learning. Some catch up in certain areas, while others need ongoing educational support. The pattern often reflects the extent of early brain and eye involvement.
How is it to live with Congenital varicella syndrome?
Living with congenital varicella syndrome can mean navigating a mix of medical needs and developmental support, depending on which organs were affected before birth. Some children may have vision or hearing differences, limb or muscle challenges that affect mobility and fine motor skills, or learning and speech differences that call for therapies and adaptive tools at school and home. Daily life often involves coordinated care—eye and hearing checks, physical and occupational therapy, and regular visits with pediatric specialists—while families learn practical routines that make activities safer and more accessible. For many, a supportive network of caregivers, teachers, and clinicians helps children participate in play, learning, and community life, and offers parents and siblings guidance, respite, and reassurance.
Treatment and drugs
Treatment for congenital varicella syndrome focuses on the baby’s needs after birth, since the infection happened during pregnancy and there’s no way to “clear” it later. Care is usually team-based and may include antiviral medicine such as acyclovir for active varicella infection, eye care for vision issues, hearing support, physical and occupational therapy for muscle stiffness or weakness, and surgery for certain limb or eye differences when appropriate. For many people, treatment begins with small daily steps, like stretching programs to prevent tight joints, glasses or low-vision aids, and early intervention services to support development. Doctors sometimes recommend a combination of lifestyle changes and drugs, and they’ll adjust the plan as your child grows and their needs change. If you’re pregnant and exposed to chickenpox, ask your doctor about immediate options such as immune globulin to reduce infection risk for the fetus, and make sure newborns with suspected congenital varicella syndrome are checked early so care can start promptly.
Non-drug treatment
Daily life with congenital varicella syndrome often centers on building skills, protecting vision and skin, and supporting growth and development. Alongside medicines, non-drug therapies can steady progress and help children participate more fully at home and school. Care typically involves a coordinated team that adjusts supports as needs change over time. Families are encouraged to seek services early and review them regularly as abilities evolve.
Time-sensitive therapies in infancy and toddler years can boost motor, language, and social skills. Addressing early symptoms of congenital varicella syndrome—such as feeding trouble or delayed head control—can improve progress.
Guided exercises help strengthen weak or underdeveloped limbs and improve balance. Therapists also work on posture, coordination, and safe movement in daily activities.
Skill-building focuses on hand function, dressing, play, and school readiness. Therapists may suggest adaptive tools to make self-care and fine motor tasks easier.
Speech-language therapy supports early communication, swallowing safety, and feeding skills. Strategies may include positioning, pacing, and texture changes to improve nutrition and reduce choking risk.
Your genes may have an impact on how drugs work for you
Some medicines used in pregnancy or after birth can act differently depending on a baby’s or pregnant person’s genes, which influence how drugs are absorbed, broken down, and cleared. Pharmacogenetic testing in select situations may guide dosing or drug choice to improve safety.
Pharmacological treatments
Treatment for congenital varicella syndrome focuses on preventing infection during pregnancy, reducing how severe varicella becomes if it occurs, and treating newborn infection; medicines cannot undo congenital changes that have already formed. Not everyone responds to the same medication in the same way. Early symptoms of congenital varicella syndrome in newborns, such as a fresh blister-like rash or trouble feeding and breathing, need urgent medical assessment to decide on antivirals and supportive care.
Varicella zoster immune globulin (VariZIG) can be given to pregnant people without immunity after close exposure and to exposed newborns, ideally within 96 hours and up to 10 days. It aims to prevent or blunt infection, lowering the chance of severe disease. It does not reverse existing features of congenital varicella syndrome.
Oral acyclovir started within about 24 hours of the rash can reduce maternal symptoms; severe illness like pneumonia may require intravenous acyclovir. This may lower how much virus circulates, but its ability to prevent congenital varicella syndrome is uncertain. Never stop or change a prescription without checking with your healthcare provider.
Valacyclovir is an oral alternative to acyclovir with better absorption and similar antiviral activity. It may be used in pregnancy after risk–benefit discussion to reduce the severity of maternal varicella. Its effect on preventing congenital varicella syndrome has not been proven.
If a newborn has suspected or confirmed varicella infection, intravenous acyclovir is used to limit viral spread and complications. Treatment does not change congenital features but can be lifesaving for active infection. Doctors adjust treatment plans regularly based on how the baby is responding.
Genetic influences
Genetic influences on congenital varicella syndrome are limited, because the condition is driven more by infection timing than family traits. Some conditions are passed down through families (inherited disorders). Congenital varicella syndrome is not one of them; it occurs when the chickenpox (varicella) virus infects a pregnant person and reaches the developing baby. If you’re wondering whether congenital varicella syndrome is inherited, it isn’t, although genes may slightly affect how strongly someone’s immune system handles the virus. This means family history usually isn’t a strong predictor, and there’s no specific gene test to gauge risk. Prior immunity from vaccination or past chickenpox—rather than inherited genes—is what most reduces the chance of the virus affecting the fetus.
Is Congenital varicella syndrome genetic?
Genetics plays little to no role in congenital varicella syndrome; it results from varicella-zoster virus exposure during early pregnancy. Inherited variants don’t drive risk. Rare immune-related differences may influence severity, but maternal infection timing is the key factor.
Pharmacogenetics—how genetics influence drug effects
While genetics doesn’t change the early symptoms of congenital varicella syndrome, it can influence how your care team selects and doses certain medicines over time. Genetic testing can sometimes identify how your body processes certain medicines, which can help your team choose safer options. When antiviral treatment is needed for active varicella-zoster infection, there aren’t specific gene tests that guide the use of acyclovir or valacyclovir; dosing is usually based on age, weight, and kidney function. If seizures are part of congenital varicella syndrome, some antiseizure drugs (like carbamazepine or phenytoin) carry a higher risk of rare but serious skin reactions in people with certain HLA gene markers, a risk seen more often in some Asian populations. For pain medicines such as codeine or tramadol after surgeries or procedures, differences in a common drug-processing gene can make the dose too weak or, in rare cases, too strong. Your doctors will weigh genetic information alongside age, organ function, other prescriptions, and goals of care to personalize treatment for congenital varicella syndrome.
Interactions with other conditions
Children born with congenital varicella syndrome may face added challenges when another illness is in the mix. Respiratory viruses or bacterial pneumonias can hit harder if there are airway differences, swallowing problems, or muscle weakness, sometimes leading to more hospital visits during cold and flu season. Skin scarring from congenital varicella syndrome can break down or get irritated, which may raise the chance of secondary skin infections during eczema flares or minor injuries. Eye involvement can make conjunctivitis or other eye infections more frequent and harder to clear, especially if vision is already reduced. Early symptoms of congenital varicella syndrome can overlap with signs of other congenital infections, such as cytomegalovirus, so teams often check for multiple causes and treat what’s found. A condition may “exacerbate” (make worse) symptoms of another, and this is especially true if a child later needs immune-suppressing medicines; in that setting, dormant varicella virus can reactivate as shingles and may be more severe without careful prevention and monitoring.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Families and midwives once noticed that some babies born after a mother had “chickenpox” early in pregnancy arrived smaller, with scars on the skin, stiff joints, or eye and brain differences. A grandmother might recall a neighbor who had chickenpox in the first months of pregnancy and later a baby who needed extra care for feeding and movement. These lived experiences preceded medical names or clear explanations.
Throughout history, people have described rashes and pregnancy-related illness that fit what we now recognize as varicella infection, but the link to specific birth differences took much longer to piece together. First described in the medical literature as a pattern of limb underdevelopment, skin scarring, and neurological changes in infants exposed in the womb, reports began to cluster in the mid-20th century as doctors compared notes from maternity and pediatric wards. From these first observations, researchers noticed that timing mattered: infections in the first half of pregnancy carried the highest risk, while later infections rarely led to the same findings.
In recent decades, awareness has grown as improved record-keeping and national surveillance allowed specialists to connect maternal varicella in early pregnancy with characteristic features seen after birth. The condition, now called congenital varicella syndrome, was further defined by advances in imaging and eye exams that clarified how the virus can affect growing tissues. As medical science evolved, detailed case series and follow-up studies helped refine estimates of risk and emphasized that, while the syndrome can be severe, it remains uncommon even when infection occurs.
Advances in genetics and virology did not change the cause—this is not an inherited disorder—but they did explain how the varicella-zoster virus travels in the bloodstream during pregnancy and can disrupt developing nerves, skin, and limbs. With the rollout of varicella vaccination programs in the 1990s and 2000s, both in the United States and parts of Europe, rates of chickenpox in the community fell, and reported cases of congenital varicella syndrome declined. Historical differences highlight why prevention and early prenatal counseling matter: when community infection rates drop, so does the chance of exposure in early pregnancy.
Over time, descriptions became more precise, and care improved. Women who are unsure of their immunity can now be tested, and those exposed during pregnancy may be offered protective treatments to lower risk. Knowing the condition’s history helps explain today’s focus on vaccination before pregnancy, rapid evaluation after exposure, and careful newborn assessments when infections occur. Each stage in history has added to the picture we have today—one in which congenital varicella syndrome is better understood, more preventable, and, in many places, thankfully rarer.